Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio - Wikidata - wikimedia - TriplyDB

Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio

Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio

http://www.wikidata.org/entity/Q36093796

about

Statin adverse effects : a review of the literature and evidence for a mitochondrial mechanism The "Statinth" wonder of the world: a panacea for all illnesses or a bubble about to burst.Statin-Induced Increases in Atrophy Gene Expression Occur Independently of Changes in PGC1α Protein and Mitochondrial Content Statin-induced Myopathy in Skeletal Muscle: the Role of Exercise Impaired redox status and cytochrome c oxidase deficiency in patients with polymyalgia rheumatica Polymorphisms in the mitochondrial ribosome recycling factor EF-G2mt/MEF2 compromise cell respiratory function and increase atorvastatin toxicity Resistance exercise reverses aging in human skeletal muscle.Monascus purpureus Went rice in nephrotic hyperlipidemia.Statin induced myopathy presenting as mechanical musculoskeletal pain observed in two chiropractic patients.Rhabdomyolysis: a review.Dietary supplementation with essential amino acids boosts the beneficial effects of rosuvastatin on mouse kidney Metabolomic high-content nuclear magnetic resonance-based drug screening of a kinase inhibitor library Pharmacotherapy of hypercholesterolaemia: statins in clinical practice.Targeting cellular energy production in neurological disorders.Effect of coenzyme Q₁₀ supplementation on heart failure: a meta-analysis The toxicology of perfluorooctanoate.Considerations for supplementing with coenzyme Q10 during statin therapy.Pharmacogenomics and pharmacogenetics of cholesterol-lowering therapy.Statin precipitated lactic acidosis?Conceptual foundations of the UCSD Statin Study: a randomized controlled trial assessing the impact of statins on cognition, behavior, and biochemistry.Simvastatin impairs ADP-stimulated respiration and increases mitochondrial oxidative stress in primary human skeletal myotubes.Evidence for metabolic aberrations in asymptomatic persons with type 2 diabetes after initiation of simvastatin therapy Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis.Prospective study of statin use and risk of Parkinson disease.Protective effects of coenzyme q(10) on decreased oxidative stress resistance induced by simvastatin.Benefit/risk ratio of statins in primary prevention.Protection of rat skeletal muscle fibers by either L-carnitine or coenzyme Q10 against statins toxicity mediated by mitochondrial reactive oxygen generation Coenzyme Q10: is there a clinical role and a case for measurement?Preventing diet induced disease: bioavailable nutrient-rich, low-energy-dense diets.CoQ10 and L-carnitine for statin myalgia?The controversy of a wider statin utilization: why?The effects of statin medications on aerobic exercise capacity and training adaptations.The role of mitochondria in statin-induced myopathy.Squalene synthase induces tumor necrosis factor receptor 1 enrichment in lipid rafts to promote lung cancer metastasis.Statins, lack of energy and ubiquinone.Statins and modulation of oxidative stress.Nightmares and sleep disturbances with simvastatin and metoprolol.HMG CoA reductase-inhibitor-related myopathy and the influence of drug interactions.Ubiquinone does not rescue acute myeloid leukemia cells from growth inhibition by statins.Effects of microcrystalline plant sterol suspension and a powdered plant sterol supplement on hypercholesterolemia in genetically obese Zucker rats.

P2860

Q24603957-44BF7E60-CB1E-436D-8CBC-688525EA901D Q24796000-7FBE6C15-9AB2-4E8B-AD84-7AB3270A288E Q27305332-5EB3F8AB-EEE7-4796-A5A8-B15CBB1EFA01 Q28086884-3C004F52-41B0-4DB7-A97B-14549D414EEA Q28361770-5AC857E6-72F5-4476-92AC-AA69F2D8564B Q28480419-EF9C644E-6485-4EC3-9685-BD45DE02CB81 Q33285479-22253B92-CDCD-4A79-BBC1-344CAFEA3554 Q33617416-85FBD44E-1E5A-4EBA-9426-B46BB52C1431 Q33692765-D350BABA-7A00-4B69-80CE-4FF590ABCB12 Q33957693-449D1A71-3D6F-4DD1-8B6C-C7A46F3C411C Q34045750-422037FB-B7C4-4B7D-8C82-33B427BC3129 Q34081089-04AA7C92-572E-4149-859B-D9E4ACC3079C Q34182077-61A65E9C-F6C6-40AA-BBD1-BB5925FC7755 Q34266266-8C3C2984-600F-4BB0-BE33-408728B9C295 Q34316289-EA68E3C7-E4E2-49C4-B321-4CAC657E4EF6 Q34343282-C826B29F-3008-4165-B72C-2953131E7C06 Q34564606-AF2F3351-6AFD-4578-A1E4-5ADF5A653733 Q35127790-DF890B86-E980-4464-82FB-DBB0B5B0B81A Q35587965-91BEF1C6-3930-48C0-914C-27804840DF5E Q35639538-F8F9CE21-2E96-446F-B1B5-46874856E63A Q35855311-3E41ADDD-A373-42C0-A535-4D620EE2926D Q35875974-01D0C9E4-484D-4758-9C63-6E25F2CD0D77 Q36017632-1E1FA382-1394-4AA0-BB41-EE5F39B4B5BF Q36100697-68399DC3-BAF3-4C62-BAEB-FD0250A7A073 Q36510647-589EB43C-204F-4ADB-8114-5638643DCD2F Q36835515-5CEC77DC-B0E4-4013-BC50-94047D82431F Q36844636-AAB31C08-5AE5-43E1-ABF2-DE47EF05AAB8 Q36869671-04FE0D5F-382E-45A4-B359-0C81F07E5707 Q37616121-D45F6BB7-C943-4A0D-8CF0-C7D3848C56DA Q38063295-7FE5320A-3D30-4EA9-BCA2-697C92377585 Q38089090-D12E5E83-6C77-43D1-A379-6936C86E4742 Q38228143-35A07ABE-60EF-469D-AA98-4209F889B445 Q38492567-67F5E717-3C84-48A8-88D5-56A9C22DBC2A Q38963276-29511519-4EFC-43CB-92CE-2A26BD6F8BDF Q42758890-CE95D8BB-A7DF-4670-9D3D-60EC19AB5794 Q43215640-9C32C6D7-0FC9-43C7-8562-ADCF1198839B Q43776207-3197D36A-59FC-415B-BE46-8CE35110A63E Q44179752-63FE9F95-98C6-4B62-93CE-188FE7E6B35F Q44279408-ED08CF1E-D74E-401F-BFAE-79EBD0F43809 Q44738497-8C48F9B3-F210-4B4C-9F7A-2C85DF851A9E

P2860

Lipid-lowering drugs and mitochondrial function: effects of HMG-CoA reductase inhibitors on serum ubiquinone and blood lactate/pyruvate ratio

http://www.wikidata.org/entity/Q36093796

description

1996 nî lūn-bûn

@nan

1996年の論文

@ja

1996年論文

@yue

1996年論文

@zh-hant

1996年論文

@zh-hk

1996年論文

@zh-mo

1996年論文

@zh-tw

1996年论文

@wuu

1996年论文

@zh

1996年论文

@zh-cn

name

Lipid-lowering drugs and mitoc ...... d blood lactate/pyruvate ratio

@ast

Lipid-lowering drugs and mitoc ...... d blood lactate/pyruvate ratio

@en

type

label

Lipid-lowering drugs and mitoc ...... d blood lactate/pyruvate ratio

@ast

Lipid-lowering drugs and mitoc ...... d blood lactate/pyruvate ratio

@en

prefLabel

Lipid-lowering drugs and mitoc ...... d blood lactate/pyruvate ratio

@ast

Lipid-lowering drugs and mitoc ...... d blood lactate/pyruvate ratio

@en

P1433

Q36093796-D376CD75-076D-4212-AC71-64A49A58BE95

P1476

Q36093796-EDEC96EA-6873-4D0A-B96E-BA11977D219B

P2093

Q36093796-156590CD-4FBE-4E72-BAF9-65406F390F3A

Q36093796-22172745-7747-4D5E-BAE5-D9A1F6EFF0BC

Q36093796-612AB5B1-A388-475A-9911-A8D4B4575B33

Q36093796-72D67769-7E96-47CF-AFED-E9CC51BCF752

Q36093796-73969ABE-37A6-4658-BAAB-4A0C62482E52

Q36093796-9B3929F1-0D4C-48C9-B42A-76C754F6525F

Q36093796-AED4E056-30E6-467E-8E84-73B11F5ACF23

Q36093796-C3961364-AE07-4959-8E24-9046D2E1B904

P304

Q36093796-33CFF139-BBDA-4D21-84B5-6E4A0DB9C7E2

P31

Q36093796-F03DE7C3-23BC-464E-8551-B9CAB0BC0050

P356

Q36093796-F3A6BA49-FE74-49ED-9796-E491FACFD82E

P407

Q36093796-B863975D-BF67-4936-B52F-1D44583094FF

P433

Q36093796-411E016C-B856-45BB-8AD9-E6E99E319D9E

P478

Q36093796-CF7C6ED7-4B19-4169-91E2-1002F4D16D2F

P577

Q36093796-BF574C54-BF4C-4185-8FE1-38E5F7DCC1EC

P5875

Q36093796-B390098F-D75E-4E20-B2DC-51F87E5FF471

P698

Q36093796-7A1C8140-D2DD-4A99-A84B-87DE8724C797

P932

Q36093796-6CFC91CA-FA03-44F4-A240-BB4220BD458C

P356

J.1365-2125.1996.04178.X

P1433

British Journal of Clinical Pharmacology

P1476

Lipid-lowering drugs and mitoc ...... d blood lactate/pyruvate ratio

@en

P2093

Ammi-Saïd M

http://www.w3.org/2001/XMLSchema#string

Astier A

http://www.w3.org/2001/XMLSchema#string

Chariot P

http://www.w3.org/2001/XMLSchema#string

De Pinieux G

http://www.w3.org/2001/XMLSchema#string

Gherardi R

http://www.w3.org/2001/XMLSchema#string

Jacotot B

http://www.w3.org/2001/XMLSchema#string

Lejonc JL

http://www.w3.org/2001/XMLSchema#string

Louarn F

http://www.w3.org/2001/XMLSchema#string

P304

333-337

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1046/J.1365-2125.1996.04178.X

http://www.w3.org/2001/XMLSchema#string

P407

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P577

1996-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

14329924

http://www.w3.org/2001/XMLSchema#string

P698

8877024

http://www.w3.org/2001/XMLSchema#string

P932

2042680

http://www.w3.org/2001/XMLSchema#string